FORA Overview

Forian Inc. is a healthtech company. It is a provider of data science-driven information and analytics solutions to the life science, healthcare and financial services industries. It provides a suite of data management capabilities and proprietary information and analytics solutions to optimize and measure the operational, clinical and financial performance of customers within the healthcare and life sciences and financial services industries. It has expertise in acquiring, integrating, normalizing and commercializing large-scale healthcare data assets. Its solutions include CHRONOS, Chartis, real-world evidence (RWE) and Kyber Data Science. CHRONOS combines open and closed claims, electronic health records, and social determinants of health data into a single, integrated model. It also provides researchers access to healthcare payers, providers, and clinical data with non-traditional healthcare sources, such as social determinants of health (SDoH) data, to uncover novel insights.

Wall Street analysts forecast FORA stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for FORA is2.10 USD with a low forecast of 2.10 USD and a high forecast of 2.10 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

Forian Inc. revenue for the last quarter amounts to 7.96M USD, increased 36.99

Forian Inc.. EPS for the last quarter amounts to -0.06 USD, decreased -700.00

Forian Inc. (FORA) has 50 emplpoyees as of April 20 2026.

Today FORA has the market capitalization of 67.17M USD.